105 related articles for article (PubMed ID: 15093886)
21. Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus.
Couture R; Girolami JP
Eur J Pharmacol; 2004 Oct; 500(1-3):467-85. PubMed ID: 15464053
[TBL] [Abstract][Full Text] [Related]
22. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
[TBL] [Abstract][Full Text] [Related]
23. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Weir R; McMurray JJ
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
[TBL] [Abstract][Full Text] [Related]
24. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
Ghanem FA; Movahed A
Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
[TBL] [Abstract][Full Text] [Related]
25. Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade.
Shah KR; Ganguly PK; Netticadan T; Arneja AS; Dhalla NS
Can J Physiol Pharmacol; 2004 Jul; 82(7):438-47. PubMed ID: 15389290
[TBL] [Abstract][Full Text] [Related]
26. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
Azadpour M; Lamas GA
Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
[TBL] [Abstract][Full Text] [Related]
27. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
[TBL] [Abstract][Full Text] [Related]
28. Long-term effects of selective and nonselective endothelin receptor antagonists in mice with heart failure.
Cavasin MA; Carretero OA; Yang F; Oja-Tebbe N; Peng H; Yang XP
J Card Fail; 2002 Aug; 8(4):254-61. PubMed ID: 12397574
[TBL] [Abstract][Full Text] [Related]
29. Estrogen and angiotensin II interactions determine cardio-renal damage in Dahl salt-sensitive rats with heart failure.
Hoshi-Fukushima R; Nakamoto H; Imai H; Kanno Y; Ishida Y; Yamanouchi Y; Suzuki H
Am J Nephrol; 2008; 28(3):413-23. PubMed ID: 18097133
[TBL] [Abstract][Full Text] [Related]
30. Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats.
Ito H; Hayashi I; Izumi T; Majima M
Br J Pharmacol; 2003 Jan; 138(1):225-33. PubMed ID: 12522094
[TBL] [Abstract][Full Text] [Related]
31. Adrenomedullary catecholamine, pressor and chronotropic responses to human coagulation beta-FXIIa mediated by endogenous kinins.
Amfilochiadis AA; Backx PH; Floras JS
J Hypertens; 2008 Jan; 26(1):61-9. PubMed ID: 18090541
[TBL] [Abstract][Full Text] [Related]
32. [Is there an indication for the association of betablockers and angiotensin II receptor antagonists in cardiac failure?].
Jondeau G; Milleron O; Morisson-Castagnet JF
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):641-6. PubMed ID: 15283038
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous diastolic contractions and phosphorylation of the cardiac ryanodine receptor at serine-2808 in congestive heart failure in rat.
Obayashi M; Xiao B; Stuyvers BD; Davidoff AW; Mei J; Chen SR; ter Keurs HE
Cardiovasc Res; 2006 Jan; 69(1):140-51. PubMed ID: 16112660
[TBL] [Abstract][Full Text] [Related]
34. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Azizi M; Ménard J
Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
[No Abstract] [Full Text] [Related]
35. Coagulation factor XIIa-kinin-mediated contribution to hypertension of chronic kidney disease.
Papageorgiou PC; Chan CT; Yeo EL; Backx PH; Floras JS
J Hypertens; 2014 Jul; 32(7):1523-33; discussion 1533. PubMed ID: 24733030
[TBL] [Abstract][Full Text] [Related]
36. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
[TBL] [Abstract][Full Text] [Related]
37. Impact of medical treatment on lung diffusion capacity in elderly patients with heart failure. Baseline characteristics and 1-year follow up after medical treatment.
Petersen CL; Kjaer A
Int J Cardiol; 2005 Feb; 98(3):453-7. PubMed ID: 15708179
[TBL] [Abstract][Full Text] [Related]
38. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.
Zhang Y; Popovic ZB; Bibevski S; Fakhry I; Sica DA; Van Wagoner DR; Mazgalev TN
Circ Heart Fail; 2009 Nov; 2(6):692-9. PubMed ID: 19919995
[TBL] [Abstract][Full Text] [Related]
39. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
de Resende MM; Mill JG
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
[TBL] [Abstract][Full Text] [Related]
40. Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth.
Ikeda Y; Hayashi I; Kamoshita E; Yamazaki A; Endo H; Ishihara K; Yamashina S; Tsutsumi Y; Matsubara H; Majima M
Cancer Res; 2004 Aug; 64(15):5178-85. PubMed ID: 15289322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
